-+ 0.00%
-+ 0.00%
-+ 0.00%

How Ingredion’s (INGR) New CFO Hire Could Shape Its Capital Allocation and Transformation Strategy

Simply Wall St·08/30/2026 23:29:57
Listen to the news
  • Ingredion has appointed Diego Reynoso, a veteran finance leader from Boston Beer, Tyson Foods and Constellation Brands, as executive vice president and chief financial officer effective October 1, 2026, succeeding interim CFO Jason Payant, who will return to a divisional finance role.
  • Reynoso’s mix of finance and operational experience across large prepared foods and beverage businesses positions him to influence Ingredion’s transformation into a global ingredient solutions provider and its enterprise productivity and capital allocation priorities.
  • We’ll now examine how bringing in Reynoso, with his background in large-scale food and beverage finance, may influence Ingredion’s investment narrative.

Outshine the giants: these 18 early-stage AI stocks could fund your retirement.

Ingredion Investment Narrative Recap

To own Ingredion, you need to believe its shift toward higher value specialty ingredients can offset pressure in legacy starch and sweetener businesses, despite recent earnings softness and emerging market volatility. The Reynoso appointment does not materially alter the near term demand and FX risks, but it could influence how tightly Ingredion manages productivity, margins and capital allocation around its most important short term catalyst: sustaining growth and profitability in Texture & Healthful Solutions.

The most relevant recent announcement is the US$1.475 billion delayed draw term loan to help fund the Tate & Lyle acquisition. That financing ties directly into Ingredion’s push to scale as a global ingredient solutions provider, which is central to the clean label and wellness catalysts. Reynoso’s experience in large, multi brand food and beverage organizations may matter to how effectively Ingredion integrates new assets and balances growth investments with balance sheet discipline.

Yet behind Ingredion’s specialty growth story, investors should be aware that persistent FX and volume pressure in key LATAM markets could...

Read the full narrative on Ingredion (it's free!)

Ingredion’s narrative projects $7.8 billion revenue and $789.5 million earnings by 2029. This requires 2.5% yearly revenue growth and an earnings increase of roughly $115 million from $674.0 million today.

Uncover how Ingredion's forecasts yield a $122.83 fair value, a 17% upside to its current price.

Exploring Other Perspectives

INGR 1-Year Stock Price Chart
INGR 1-Year Stock Price Chart

The most optimistic analysts were assuming revenues near US$7.9 billion and earnings around US$806.7 million by 2029, which is far more upbeat than consensus and could be challenged if operational issues like recurring Argo facility disruptions are not addressed under the new CFO.

Explore 4 other fair value estimates on Ingredion - why the stock might be worth 16% less than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Ingredion research is our analysis highlighting 4 key rewards that could impact your investment decision.
  • Our free Ingredion research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ingredion's overall financial health at a glance.

Curious About Other Options?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.